Cockroft Bettina M. 4/A
4/A · CNS Pharmaceuticals, Inc. · Filed Aug 10, 2023
Insider Transaction Report
Form 4/AAmended
Cockroft Bettina M.
Director
Transactions
- Award
Option to purchase common stock
2023-05-05+2,099→ 2,099 totalExercise: $1.67Exp: 2033-05-05→ Common Stock (2,099 underlying)
Footnotes (2)
- [F1]The options set forth in this table vest in 36 equal monthly installments succeeding the issuance date, or May 5, 2023, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.
- [F2]The options were issued in connection with the reporting person's Board of Director services to the Company.